Study guide

8.2 Delirium and Terminal Restlessness

Certified Hospice and Palliative Nurse CHPN

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Fees, Windows, and Retakes 1.3 Scoring, Test-Day Rules, and Remote Proctoring 1.4 Recertification: HPAR and the Situational Judgment Exercise

2 Chapter 2: Assessment, Goals, and Care Planning

2.1 Goals of Care and Shared Decision Making 2.2 Interdisciplinary Care Planning and Ongoing Evaluation 2.3 Prognostic and Functional Assessment Tools 2.4 Levels of Care and Care-Setting Transitions

3 Chapter 3: Life-Limiting Disease Progression I

3.1 Cancer, Hematologic, and Paraneoplastic Complications 3.2 Heart Failure and Cardiac Disease Progression 3.3 Pulmonary Disease Progression 3.4 Neurologic Disease Progression

4 Chapter 4: Disease Progression II and Imminent Death

4.1 Dementia, Frailty, and Feeding Decisions 4.2 Renal, Hepatic, and Endocrine Trajectories 4.3 Indicators of Imminent Death

5 Chapter 5: Pain Assessment

5.1 Pain Types, Etiology, and Syndromes 5.2 Verbal and Nonverbal Pain Assessment and Scales 5.3 Factors That Influence the Pain Experience

6 Chapter 6: Pharmacologic Pain Management

6.1 Opioid and Non-Opioid Analgesics by Pain Type and Severity 6.2 Adjuvant Analgesics 6.3 Titration, Baseline Dosing, and Breakthrough Pain 6.4 Equianalgesic Conversion and Route Changes

7 Chapter 7: Nonpharmacologic Pain and Opioid Safety

7.1 Nonpharmacologic Pain Interventions 7.2 Complementary and Integrative Pain Therapies 7.3 Opioid Adverse Effects, Neurotoxicity, and Rotation

8 Chapter 8: Neurological, Cardiovascular, and Respiratory Symptoms

8.1 Neurological Symptoms 8.2 Delirium and Terminal Restlessness 8.3 Cardiovascular Symptoms 8.4 Respiratory Symptoms: Dyspnea, Cough, and Secretions

9 Chapter 9: Gastrointestinal, Genitourinary, and Musculoskeletal Symptoms

9.1 Gastrointestinal Symptoms 9.2 Genitourinary Symptoms 9.3 Musculoskeletal Symptoms

10 Chapter 10: Skin, Metabolic, Hematologic, and Psychospiritual Symptoms

10.1 Skin and Mucous Membrane Symptoms 10.2 Nutritional and Metabolic Symptoms 10.3 Immune and Hematologic Symptoms 10.4 Psychosocial, Emotional, and Spiritual Symptom Burden

11 Chapter 11: Advance Care Planning, Benefits, and Safety

11.1 Advance Care Planning and Life-Sustaining Therapies 11.2 Hospice and Palliative Benefits under Medicare, Medicaid, and Private Insurance 11.3 Patient Safety: Environmental, Physical, and Socioemotional

12 Chapter 12: Communication, Culture, and Psychosocial Support

12.1 Communication Techniques, Barriers, and Family Meetings 12.2 Cultural Humility and Spiritual Needs 12.3 Psychosocial Needs and IDG Participation

13 Chapter 13: Caregiver Education and Medication Management

13.1 Medication Management and Controlled Substances 13.2 Caregiver and Family Self-Care 13.3 Teaching End-Stage Disease, Pain, and Symptom Plans 13.4 Caregiver Skills, DME, Supplies, and Services

14 Chapter 14: Grief, Death, and End-of-Life Ethics

14.1 Grief, Loss, and Bereavement 14.2 Support at the Time of Death and Post-Mortem Care 14.3 Ethical Issues Related to End of Life

15 Chapter 15: Medicare Hospice Compliance and National Standards

15.1 Medicare Hospice Benefit and Conditions of Participation 15.2 Hospice Eligibility, Admission, and Recertification 15.3 National Hospice and Palliative Care Standards 15.4 National Consensus Project Clinical Practice Guidelines

16 Chapter 16: Legal, Professional Practice, Quality, and Policy

16.1 Legal Regulations: CMS, HIPAA, and OSHA 16.2 Professional Boundaries and Ethics 16.3 QAPI, Self-Care, and Precepting 16.4 Policy, Delivery, and Reimbursement Trends

8.2 Delirium and Terminal Restlessness

Key Takeaways Explain This Topic AI

Delirium is hyperactive, hypoactive, or mixed; hypoactive delirium is common in palliative care and is the type most often missed.

The Confusion Assessment Method requires acute onset with fluctuation plus inattention, and either disorganized thinking or altered consciousness.

High-yield reversible causes include urinary tract infection, hypoxia, constipation, urinary retention, medications, and hypercalcemia.

Haloperidol is first-line for distressing delirium in many hospice protocols; benzodiazepines often worsen delirium except when the patient is dying, catatonic, seizing, or in alcohol withdrawal.

Terminal agitation is not a diagnosis of exclusion until pain, retention, and other reversible drivers have been considered; teach families that delirium is a medical symptom.

Last updated: August 2026

Delirium is a symptom, not a personality change

Delirium is an acute disturbance of attention and awareness that fluctuates. It is one of the highest-yield non-pain symptoms in Domain 3 because it distresses families, predicts nearer death, and is often partly reversible even in hospice. CHPN items punish two errors: missing hypoactive delirium, and treating every moan in the last hours as "terminal restlessness" without looking for pain or a full bladder.

Motor subtypes

Subtype What you see Exam trap

Hyperactive Agitation, picking, pulling at clothes or catheters, hallucinations, climbing Easy to notice; easy to over-sedate

Hypoactive Withdrawal, sparse speech, drowsiness, poor eye contact, still inattentive Looks like "tired" or "depressed"; most often missed

Mixed Fluctuates between the two across the day Night agitation with daytime sleepiness is still delirium

Hypoactive delirium is more common in palliative and hospital populations than the shouting picture families expect. A quiet patient who cannot follow a simple instruction is not "peacefully sleeping it off" until you have assessed attention.

Confusion Assessment Method (CAM) features

The Confusion Assessment Method (CAM) is the bedside frame CHPN expects you to know conceptually:

  • Acute onset and fluctuating course , and
  • Inattention (cannot focus, loses the thread, cannot count or recite months backward),
  • plus either
  • Disorganized thinking , or

Altered level of consciousness (hyperalert or drowsy).

You need features 1 and 2, plus 3 or 4. Chronic dementia can coexist, but dementia alone is not CAM-positive unless something new and fluctuating has been added. That "new" is often infection, a drug, constipation, or hypoxia.

Reversible causes before a label of dying

Even in the last weeks, a short search for drivers is nursing work, not a betrayal of hospice philosophy. The usual CHPN list is practical rather than encyclopedic: urinary tract infection , hypoxia , constipation / fecal impaction , urinary retention , medications , and hypercalcemia . Medications that commonly tip a vulnerable brain include anticholinergics, benzodiazepines, corticosteroids, and opioids (especially after a rapid increase). Hypercalcemia in solid tumors produces polyuria, constipation, thirst, and confusion; treating it is appropriate when the patient can still benefit and when goals include more alert time.

Other contributors worth a glance: untreated pain, sensory deprivation (missing glasses or hearing aids), sleep disruption, hyponatremia, hepatic encephalopathy, and withdrawal from alcohol or benzodiazepines. You do not order every test in a dying patient. You do ask: is there a catheter or a palpable bladder , a last bowel movement , a new drug , an oxygen saturation , and a fever or dysuria story ?

Pharmacologic choices that CHPN tests

Nonpharmacologic care is first whenever it can help: glasses and hearing aids on, clock and daylight, a familiar person at the bedside, fewer overnight interruptions, and no arguing with a hallucination (redirect, do not debate). When delirium is distressing —fear, dangerous agitation, or exhaustion of the patient and family—medication is indicated.

Haloperidol is first-line in many hospice protocols for distressing delirium. It is an antipsychotic used at low doses, by oral or subcutaneous or intravenous routes depending on setting. The point on the exam is priority and class, not a brand name. Reserve dose-chasing for the prescriber; the nursing judgment is that an antipsychotic, not a large benzodiazepine, is the usual first drug when the patient is not in one of the exception categories below.

Benzodiazepines can worsen delirium. They increase confusion, falls, and paradoxical agitation in many seriously ill adults. Exceptions you should memorize:

The patient is imminently dying and terminal restlessness persists after attention to pain and after a neuroleptic, or the team is using a planned palliative sedation pathway.

Catatonia (specialist-guided).

Seizure (treat the seizure).

Alcohol or benzodiazepine withdrawal (here a benzodiazepine is treatment, not a mistake).

If the stem is a still-verbal patient with new inattention and no withdrawal or seizure, more lorazepam as monotherapy is usually the wrong answer .

Terminal agitation versus untreated pain

Terminal restlessness (also called terminal agitation) appears in the last hours to days: nonpurposeful movement, moaning without a clear nociceptive trigger, picking at linens. It overlaps delirium. Untreated pain looks different if you watch care: grimacing, guarding, tachycardia or tachypnea with turning or wound care, and relief after an opioid. A distended bladder or impacted rectum can look identical to "fighting death." CHPN will offer a benzodiazepine in the options; the better first action is often assess and treat pain, urinary retention, and constipation , then use protocol drugs for remaining distress.

Cause checklist

Check Why it matters First nursing move

Urinary tract infection Classic reversible delirium in older and catheterized patients History, urinalysis if it will change care, treat if consistent with goals

Hypoxia Air hunger and confusion travel together Oxygen if hypoxic and tolerated; fan and opioid for dyspnea (Section 8.4)

Constipation / impaction Full rectum is an agitator Last bowel movement, abdominal exam, suppository or enema if appropriate

Urinary retention Palpable bladder, overflow, restlessness with turning Bladder scan or in-and-out catheter per protocol

Medications Anticholinergics, benzodiazepines, steroids, opioid surge Deprescribe what you can; rotate opioid if myoclonus or toxicity

Hypercalcemia Myeloma, breast, lung, and other solid tumors Hydration and disease-directed treatment only if goals and prognosis support it

Pain versus dying Grimace with care versus purposeless terminal movement Trial analgesic; do not skip assessment

Family teaching

Teach that delirium is a medical symptom of a sick brain , not the patient "going crazy" or "giving up." Hypoactive delirium still counts. Do not argue with visions; offer reassurance that the team is treating causes and distress. Explain that a calm presence, familiar voices, and restored glasses often help more than another sedative. If death is near, name terminal restlessness honestly: the goal is comfort, not a perfectly still body at the expense of unassessed pain. Invite the interdisciplinary team—medicine, social work, chaplaincy—when family conflict or spiritual distress is driving requests for "something to knock them out." That request is data; it is not automatically the order.